Reaktivacija citomegalovirusa (CMV) tijekom liječenja kroničnog hepatitisa C genotipa 1B (CROSBI ID 655149)
Prilog sa skupa u zborniku | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Petković, Dobrinka ; Vuković, Borislav ; Andrić, Zdravko
hrvatski
Reaktivacija citomegalovirusa (CMV) tijekom liječenja kroničnog hepatitisa C genotipa 1B
The aim was todemonstate the clinical course of chronic hepatitis C genotype 1b treated by combination of pegylated interferon alfa-2a and ribavirin with therapeutic rapid and sustained viral response, negativization HCV RNA in serum and significant regression of fibrosis grade.As a side effect of combination therapy was reactivation of CMV.
kronični hepatitis c, pegilirani interferon alfa-2a i ribavirin, reaktivacija citomegalovirusa
nije evidentirano
engleski
Reactivation of cytomegalovirus (CMV) for the treatment of chronic hepatitis C of genotype 1B
nije evidentirano
chronic hepatitis C ; pegylated interferon alpha-2a and ribavirin, reactivation of cytomegalovirus
nije evidentirano
Podaci o prilogu
415-419.
2016.
objavljeno
Podaci o matičnoj publikaciji
5th International Conference "Vallis Aurea" - focus on: research and innovation: Proceedings
Katalinić, Branko
Požega : Beč:
Podaci o skupu
5 th International Conference Vallis Aurea Focus on Research and Innovation
predavanje
22.09.2016-24.09.2016
Požega, Hrvatska
